Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Iscept L 1.25 mg/250 mg Tablet

Prescription Icon
Prescription Required

Marketer

Strides shasun Ltd

Salt Composition

Glibenclamide (1.25mg) + Metformin (250mg)

Overview Iscept L 1.25 mg/250 mg Tablet

Diabex Duo 1.25 mg/250 mg tablets are classified as antidiabetic medications, combining two drugs to manage type 2 diabetes in adults. This formulation helps regulate blood glucose in diabetic patients. Diabex Duo should be administered with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on blood sugar monitoring. Continued use is crucial, even with controlled blood sugar, as premature discontinuation, without medical consultation, can elevate glucose levels, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan including diet, exercise, and weight management as advised by your doctor. Lifestyle choices significantly impact diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by sweating, dizziness, headache, and tremors. Recognize these symptoms and carry a quick-acting glucose source, like sugary foods or juice. Alcohol consumption increases hypoglycemia risk and should be limited. Other potential side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe liver or kidney disease. Prior heart conditions should be disclosed to your physician before commencing treatment. Pregnant or breastfeeding individuals should seek medical advice. Regular blood glucose monitoring is essential, along with potential blood tests to track blood cell counts and liver function.

Uses of Iscept L 1.25 mg/250 mg Tablet

Managing type 2 diabetes

Major Benefits of Iscept L 1.25 mg/250 mg Tablet:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Iscept L 1.25 mg/250 mg Tablet should be administered with a meal.

Common Side effects of Iscept L 1.25 mg/250 mg Tablet:

  • Nausea
  • Vomiting
  • Diarrhea
  • Flatulence

How to use Iscept L 1.25 mg/250 mg Tablet:

Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The Iscept L 1.25 mg/250 mg Tablet should be administered with a meal.

How Iscept L 1.25 mg/250 mg Tablet works:

Each Iscept L 1.25 mg/250 mg tablet contains glibenclamide and metformin, two medications used to manage blood sugar levels in individuals with diabetes.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol alongside Iscept L 1.25 mg/250 mg Tablet is inadvisable due to safety concerns.

PregnancyPregnancySAFE IF PRESCRIBED

Pregnancy use of Iscept L 1.25 mg/250 mg tablets is typically deemed safe. Preclinical trials in animals revealed minimal or no harm to the fetus; however, data from human trials are scarce.

Breast feedingBreast feedingCAUTION

The use of Iscept L 1.25 mg/250 mg tablets necessitates careful consideration during lactation. Breastfeeding should be temporarily discontinued throughout the mother's treatment course and until complete drug excretion.

DrivingDrivingCONSULT YOUR DOCTOR

The effect of Iscept L 1.25 mg/250 mg Tablet on driving ability is undetermined. Refrain from driving if experiencing symptoms impairing concentration or reaction time.

KidneyKidneyUNSAFE

Patients with kidney disease should likely avoid Iscept L 1.25 mg/250 mg Tablets, as their use may be unsafe. Medical advice is recommended.

LiverLiverCAUTION

Patients with liver disease should use Iscept L 1.25 mg/250 mg tablets cautiously, potentially requiring dose modification. Consult a physician. For those with mild to moderate liver impairment, initiate treatment with a low Iscept L 1.25 mg/250 mg tablet dosage; however, it's contraindicated in patients with severe liver disease.

What if you forget to take Iscept L 1.25 mg/250 mg Tablet :

Should you forget to take your Iscept L 1.25 mg/250 mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Iscept L 1.25 mg/250 mg Tablet

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Iscept L 1.25 mg/250 mg Tablet

Iscept L 1.25 mg/250 mg tablets combine glibenclamide and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glibenclamide stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. This medication is not suitable for type 1 diabetes.
Type 2 diabetes, the most prevalent form of diabetes, occurs when the body doesn't produce sufficient insulin or the insulin produced is ineffective. This results in elevated blood glucose levels, causing various health issues. Symptoms of high blood sugar include excessive thirst, frequent urination, and increased hunger. Untreated, type 2 diabetes can lead to long-term complications such as nerve damage (neuropathy), kidney damage (nephropathy), eye damage (retinopathy), foot problems, and an increased risk of cardiovascular disease.
Iscept L 1.25 mg/250 mg Tablets may cause common side effects such as low blood sugar (hypoglycemia), altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Iscept L 1.25 mg/250 mg Tablets can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heartbeat, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Prolonged Iscept L 1.25 mg/250 mg Tablet use can interfere with vitamin B12 absorption, leading to deficiency. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and ataxia), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Iscept L 1.25 mg/250 mg Tablet is contraindicated in patients with known allergies to its components or excipients, those with moderate to severe kidney disease, and those with underlying metabolic acidosis, including diabetic ketoacidosis.
Combining Iscept L 1.25 mg/250 mg tablets with alcohol is unsafe. This combination can worsen low blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Iscept L 1.25 mg/250 mg T...
24
MRP 29
17% off